Hasegawa Maki, Kusuhara Hiroyuki, Sugiyama Daisuke, Ito Kousei, Ueda Shirou, Endou Hitoshi, Sugiyama Yuichi
Graduate School of Pharmaceutical Sciences, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan.
J Pharmacol Exp Ther. 2002 Mar;300(3):746-53. doi: 10.1124/jpet.300.3.746.
Our previous kinetic analyses have shown that the transporter responsible for the renal uptake of pravastatin, an HMG-CoA reductase inhibitor, differs from that involved in its hepatic uptake. Although organic anion transporting polypeptides are now known to be responsible for the hepatic uptake of pravastatin, the renal uptake mechanism has not been clarified yet. In the present study, the involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of pravastatin was investigated. Immunohistochemical staining indicates the basolateral localization of rOat3 in the kidney. rOat1- and rOat3-expressed LLC-PK1 cells exhibited specific uptake of p-aminohippurate (PAH) and pravastatin, respectively, with the Michaelis-Menten constants (Km values) of 60 microM for rOat1-mediated PAH uptake and 13 microM for rOat3-mediated pravastatin uptake. Saturable uptake of PAH and pravastatin was observed in kidney slices with Km values of 69 and 11 microM, respectively. The difference in the potency of PAH and pravastatin in inhibiting uptake by kidney slices suggests that different transporters are responsible for their renal uptake. This was also supported by the difference in the degree of inhibition by benzylpenicillin, a relatively selective inhibitor of rOat3, for the uptake of PAH and pravastatin by kidney slices. These results suggest that rOat1 and rOat3 are mainly responsible for the renal uptake of PAH and pravastatin, respectively.
我们之前的动力学分析表明,负责肾摄取HMG-CoA还原酶抑制剂普伐他汀的转运体与其肝摄取所涉及的转运体不同。虽然现在已知有机阴离子转运多肽负责普伐他汀的肝摄取,但肾摄取机制尚未阐明。在本研究中,研究了大鼠有机阴离子转运体3(rOat3;Slc22a8)在普伐他汀肾摄取中的作用。免疫组织化学染色显示rOat3在肾脏的基底外侧定位。表达rOat1和rOat3的LLC-PK1细胞分别表现出对对氨基马尿酸(PAH)和普伐他汀的特异性摄取,rOat1介导的PAH摄取的米氏常数(Km值)为60 microM,rOat3介导的普伐他汀摄取的Km值为13 microM。在肾切片中观察到PAH和普伐他汀的饱和摄取,Km值分别为69和11 microM。PAH和普伐他汀抑制肾切片摄取的效力差异表明,不同的转运体负责它们的肾摄取。苄青霉素是rOat3的相对选择性抑制剂,其对肾切片摄取PAH和普伐他汀的抑制程度差异也支持了这一点。这些结果表明,rOat1和rOat3分别主要负责PAH和普伐他汀的肾摄取。